Noscira Patents – Insights & Stats (Updated 2023)

Noscira has a total of 181 patents globally, out of which 63 have been granted. Of these 181 patents, more than 15% patents are active. Europe (EPO) is where Noscira has filed the maximum number of patents, followed by Japan and the USA. Parallelly, Europe (EPO) seems to be the main focused R&D center of Noscira and Spain is the origin country of the firm.

Noscira was founded in the year 2000. Company is a spanish biopharmaceutical company focused on the research and development of new drugs to fight against neurodegenerative diseases.

Do read about some of the most popular patents of Noscira which have been covered by us in this article and also you can find Noscira patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Noscira patent portfolio.

How many patents does Noscira have?

Noscira has a total of 181 patents globally. These patents belong to 31 unique patent families. Out of 181 patents, 28 patents are active.

How Many Patents did Noscira File Every Year?

Noscira Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant Noscira Applications Filed Noscira Patents Granted
2022
2021
2020
2019
2018
2017 1
2016
2015
2014 1
2013 3 3
2012 2 14
2011 7 14

How many Noscira patents are Alive/Dead?

Worldwide Patents Noscira Patent Portfolio

How Many Patents did Noscira File in Different Countries?

Noscira Worldwide Patent Filing Countries in which Noscira Filed Patents

Country Patents
Europe 20
Japan 13
United States Of America 12
Australia 10
Canada 9
Russia 9
Korea (South) 8
Mexico 8
India 6
Israel 6
China 6
Austria 5
Brazil 5
Portugal 5
Morocco 5
New Zealand 5
Norway 5
Hong Kong (S.A.R.) 4
South Africa 4
Germany 4
Spain 4
Singapore 3
Poland 3
Chile 3
Denmark 2
Cyprus 1
Slovenia 1
Croatia 1
Serbia 1

Where are Research Centres of Noscira Patents Located?

R&D Centres of Noscira

10 Best Noscira Patents

JP2007534616A is the most popular patent in the Noscira portfolio. It has received 17 citations so far from companies like Pfizer.  Below is the list of 10 most cited patents of Noscira: 

Publication Number Citation Count
JP2007534616A 17
WO2013124413A1 15
WO2011151359A1 14
WO2012069428A1 13
WO2008015240A1 11
US8158661B2 10
WO2008015241A1 8
WO2008152068A2 6
US20090192204A1 3
EP2444121A1 3

What are Noscira key innovation segments?

What Technologies are Covered by Noscira?

The chart below distributes patents filed by Noscira in different countries on the basis of the technology protected in patents. It also represents the markets where Noscira thinks it’s important to protect particular technology inventions.

R&D Focus: How has Noscira search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Noscira?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.